Iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9840526
SERIAL NO

15661288

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Bromodomain-containing protein 4 (BRI)) has recently emerged as an attractive epigenetic target for anticancer therapy. Iridium(III) complexes are useful as irreversible inhibitor of BRD4. Complex 1a of the formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KAOHSIUNG MEDICAL UNIVERSITY100 SHIH-CHUAN 1ST RD KAOHSIUNG CITY 807
HONG KONG BAPTIST UNIVERSITYKOWLOON TONG KOWLOON
UNIVERSITY OF MACAUTHE UNIVERSITY OF MACAO TAIPA CHINA MACAO MACAO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Leung, Chung-Hang Macau, CN 5 2
Ma, Dik-Lung Kowloon, HK 7 5
Wang, Hui-Min Kaohsiung, TW 46 232
Zhong, Hai-Jing Macau, CN 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00